Clinical Trials Sponsored by Millennium Pain Center

Total 395 results

Millennium Pain Center

Terminated

Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain

Osteoarthritis, Knee

United States
Millennium Pain Center

Completed

Trialing of ISS in Patients With CRPS

Causalgia | CRPS I

United States
Pain Management Center of Paducah
Millennium Laboratories

Completed

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients

Chronic Pain
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy

Lymphoma, B-Cell

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Active, not recruiting

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies

Advanced Cancers

United States
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Brain and Central Nervous System Tumors

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation

Leukemia

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Acupuncture for Chemo-Induced Peripheral Neuropathy

Lymphoma | Peripheral Neuropathy | Myeloma

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

Lymphoma | Mantle Cell Lymphoma

United States
Gramercy Pain Center

Recruiting

Treatment of Shoulder Osteoarthritis

Chronic Shoulder Pain

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Active, not recruiting

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

Solid Tumor | Urethral Cancer

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma

Lung Cancer | Mesothelioma

United States
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Lymphoma

United States
Fox Chase Cancer Center
Millennium Pharmaceuticals, Inc.

Terminated

Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Recurrent

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Withdrawn

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

Malignant Neoplasms of Female Genital Organs | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Digestive Organs | Malignant Neoplasms of Male Genital Organs
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Lymphoma | Hodgkin Lymphoma

United States
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.

Active, not recruiting

Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study

Multiple Myeloma | High Risk Smoldering Multiple Myeloma

United States
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D

Non-Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients

Metastatic Castration-Resistant Prostate Cancer

United States
Samsung Medical Center
Millennium Pharmaceuticals, Inc.

Completed

Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas (BRAN)

Non-Hodgkin Lymphoma

Korea, Republic of
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Amyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)

United States
UNC Lineberger Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Terminated

A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas

Follicular Lymphoma | Burkitt Lymphoma | Diffuse Large B-cell Lymphoma

United States
Danish Pain Research Center

Completed

Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations

Neuropathic Pain | Neuroma

Denmark
Regenerative Pain Center, Illinois

Completed

Outcomes Data of Bone Marrow Stem Cells to Treat Hip and Knee Osteoarthritis

Hip and Knee Osteoarthritis

United States
Danish Pain Research Center

Completed

Pain After Stroke, Part 2: Clinical Characteristics and Classification of Pain in Patients After Stroke

Pain
Danish Pain Research Center

Completed

Evaluation of Autonomic Cardiac Function in Patients With CRPS

CRPS (Complex Regional Pain Syndromes)

Denmark
Danish Pain Research Center

Completed

Neuropathic Pain and Fabry Disease

Fabry Disease

Denmark
Masonic Cancer Center, University of Minnesota
Millennium Pharmaceuticals, Inc.

Terminated

Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders

Lymphoproliferative Disorder

United States
M.D. Anderson Cancer Center
Genentech, Inc.; Millennium Pharmaceuticals, Inc.

Withdrawn

Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)

Lung Cancer
Danish Pain Research Center

Completed

Pain Processing in Anxiety and Depression

Depression | Pain | Anxiety

Denmark
Danish Pain Research Center

Completed

Descriptive Study of Pain, Anxiety and Depression

Pain

Denmark
Pain Cure Center, California

Completed

Noxipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation for Chronic Pain

Neck Pain | Shoulder Pain

United States
Danish Pain Research Center

Completed

Treatment With Spinal Cord Stimulation: Effect on Sensory Parameters

Chronic Pain

Denmark
Danish Pain Research Center

Completed

Central Post-Stroke Pain - a Prospective Study

Pain
Danish Pain Research Center

Completed

Capsaicin-Evoked Pain in Patients With CRPS

CRPS (Complex Regional Pain Syndromes)

Denmark
Danish Pain Research Center

Completed

Oxycodone vs Fentanyl for Pain Treatment After Laparoscopic Cholecystectomy

Pain

Denmark
Boston Medical Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Amyloidosis

United States
M.D. Anderson Cancer Center
Millennium: The Takeda Oncology Company

Completed

Study of Ixazomib and Erlotinib in Solid Tumors

Solid Tumors

United States
Ohio State University Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Terminated

Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditions

United States
M.D. Anderson Cancer Center
Millennium: The Takeda Oncology Company

Terminated

Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission

Leukemia

United States
Masonic Cancer Center, University of Minnesota
Millennium Pharmaceuticals, Inc.

Terminated

Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

United States
University of Michigan Rogel Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma

Neuroblastoma

United States
Dartmouth-Hitchcock Medical Center
Millennium Pharmaceuticals, Inc.

Completed

Low Dose Melphalan and Bortezomib for AML and High-Risk MDS

Myelodysplastic Syndromes | Acute Myelogenous Leukemia

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.

Completed

Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone

Prostate Cancer

United States
Pain Management Center of Paducah

Completed

Effectiveness of Percutaneous Lumbar Epidural Adhesiolysis and Neurolysis on Low Back Pain

Low Back Pain

United States
Pain Management Center of Paducah

Completed

Effectiveness of Thoracic Facet Joint Nerve Blocks

Low Back Pain

United States

Clinical Trials Sponsored by Millennium Pain Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations